|CRDAMC Homepage | CRDAMC Library Phone #: (254) 288-8366 | CRDAMC Library Fax #: (254) 288-8368|
June 02, 2013
Experimental Drug Shows Benefits Against Melanoma in Early Study
SUNDAY, June 2 (HealthDay News) -- A new drug called lambrolizumab appears to improve outcomes in patients with advanced melanoma, according to the results of a phase 1 trial.
Doubling Time on Tamoxifen Cuts Odds for Breast Cancer's Return: Study
SUNDAY, June 2 (HealthDay News) -- When it comes to using the drug tamoxifen to prevent breast cancer's return, longer may be better for some patients, a new study finds.
Avastin May Boost Survival in Advanced Cervical Cancer: Study
SUNDAY, June 2 (HealthDay News) -- The cancer drug Avastin may extend the lives a bit of women with advanced cervical cancer, a new study says.
Drug May Work Against Advanced Thyroid Cancer
SUNDAY, June 2 (HealthDay News) -- A drug already used for advanced kidney and liver cancers may help slow the progression of thyroid cancers that do not respond to standard treatment, a new clinical trial finds.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at email@example.com. Our Health Library Support team will respond to your email request within 2 business days.